Prosecution Insights
Last updated: May 29, 2026

Berg Hill Greenleaf & Ruscitti LLP

28 pending office actions • 15 clients • 28 examiners • 24 art units • 0 of 28 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days

Portfolio Summary

28
Total Pending OAs
19
Non-Final OAs
9
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 28 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

17
Overdue
1
Due this week
6
Due this month
2
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 28 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (17)Due ≤ 7 days (1)Due ≤ 30 days (6)Due ≤ 60 days (2)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (4%)
18
Medium (64%)
8
Easy (29%)
1
Unknown (4%)

Rejection Statute Mix

BucketCases
§101 only1 (4%)
§103 only16 (57%)
§102 only2 (7%)
§112 only7 (25%)
Double-patenting only1 (4%)
No statute on record1 (4%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

22
Life Sciences
79% of docket
0
Information Tech
0% of docket
1
Communications
4% of docket
1
Semiconductors
4% of docket
4
Mechanical / Eng
14% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

280 h
Manual time on pending OAs
56 h
Time saved (low, 20%)
98 h
Time saved (mid, 35%)
2.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SHEN, YANXIN NMN 1 100.0% +0.0%
JOHNSON, EMILY KATHARINE 1 100.0% +0.0%
RODRIQUEZ, KARI KRISTIN 1 55.4% +38.1%
CASTELLANO, STEPHEN J 1 64.9% +36.1%
BROUGHTON, KATHLEEN M 1 84.0% +9.0%
SODERQUIST, ARLEN 1 59.6% +26.9%
HUANG, GIGI GEORGIANA 1 31.8% +30.4%
HUANG, MICKEY NMN 1 61.5% +50.4%
ZIEGLER, MATTHEW D 1 47.5% +53.7%
LEGESSE, HENOK D 1 86.3% +2.0%

Quick Wins (4)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18925537 ENHANCED PRODUCTION OF SQUALENE IN PLANT SYSTEMS JOHNSON, EMILY KATHARINE 60d overdue
18925427 HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS SHEN, YANXIN NMN 9d
18267575 SYSTEM AND METHOD FOR MANUFACTURING STRIPS CONTAINING LABELS WITH VARIABLE INFORMATION PRINTED BY THERMAL TRANSFER LEGESSE, HENOK D 16d
18701601 SYSTEM AND METHODS FOR ANALYZING MULTICOMPONENT CELL AND MICROBE SOLUTIONS AND METHODS OF DIAGNOSING BACTEREMIA USING THE SAME BROUGHTON, KATHLEEN M 22d

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17744536 Identification of Host RNA Biomarkers of Infection VANNI, GEORGE STEVEN 89d overdue

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18657116 ANIMAL WASTE STORAGE DEVICE CASTELLANO, STEPHEN J 50d overdue
18787496 COMPRESSIVE ORTHOTIC DEVICE AND METHODS OF USE THEREOF RODRIQUEZ, KARI KRISTIN 15d overdue
18237251 LIPID NANOPARTICLE (LNP) ENCAPSULATION OF MRNA PRODUCTS HUANG, MICKEY NMN 3d overdue
18625514 CHEMILUMINESCENCE MICROFLUIDIC IMMUNOASSAY DEVICE AND METHODS OF USE THEREOF SODERQUIST, ARLEN 28d
18276147 DEVICE FOR TRANSFERRING ENERGY BETWEEN EXHALING AND INHALING PHASES ZIEGLER, MATTHEW D 41d
18603489 1-METHYL-1H-PYRAZOL-3-YL DERIVATIVES FOR USE IN THE TREATMENT OF NEOVASCULAR DISEASES HUANG, GIGI GEORGIANA 84d

Client Portfolio (15 clients)

Top Art Units

Art UnitApps
16622
17972
17582
16562
16631
37861
37331
26611
16131
37851

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18925427 HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS The Regents of the University of Colorado SHEN, YANXIN NMN 1663 §103 Non-Final OA 9d Pending Oct 24, 2024
18925537 ENHANCED PRODUCTION OF SQUALENE IN PLANT SYSTEMS The Regents of the University of Colorado JOHNSON, EMILY KATHARINE 1662 §103 Non-Final OA 60d overdue Pending Oct 24, 2024
18787496 COMPRESSIVE ORTHOTIC DEVICE AND METHODS OF USE THEREOF Quorum Orthopedics, Inc. RODRIQUEZ, KARI KRISTIN 3786 §103 Non-Final OA 15d overdue Pending Jul 29, 2024
18657116 ANIMAL WASTE STORAGE DEVICE Balloon Innovations, Inc. CASTELLANO, STEPHEN J 3733 §103 Final Rejection 50d overdue Pending May 07, 2024
18701601 SYSTEM AND METHODS FOR ANALYZING MULTICOMPONENT CELL AND MICROBE SOLUTIONS AND METHODS OF DIAGNOSING BACTEREMIA USING THE SAME The Regents of the University of Colorado BROUGHTON, KATHLEEN M 2661 §103 Non-Final OA 22d Pending Apr 15, 2024
18625514 CHEMILUMINESCENCE MICROFLUIDIC IMMUNOASSAY DEVICE AND METHODS OF USE THEREOF ZYMO RESEARCH CORPORATION SODERQUIST, ARLEN 1797 §112 Final Rejection 28d Pending Apr 03, 2024
18603489 1-METHYL-1H-PYRAZOL-3-YL DERIVATIVES FOR USE IN THE TREATMENT OF NEOVASCULAR DISEASES Exonate Limited HUANG, GIGI GEORGIANA 1613 DP Non-Final OA 84d Pending Mar 13, 2024
18237251 LIPID NANOPARTICLE (LNP) ENCAPSULATION OF MRNA PRODUCTS Nature'S Toolbox, Inc. HUANG, MICKEY NMN 1758 §103 Non-Final OA 3d overdue Pending Aug 23, 2023
18276147 DEVICE FOR TRANSFERRING ENERGY BETWEEN EXHALING AND INHALING PHASES Srs Serviços Relacionados A Saude Ltda ZIEGLER, MATTHEW D 3785 §103 Non-Final OA 41d Pending Aug 07, 2023
18267575 SYSTEM AND METHOD FOR MANUFACTURING STRIPS CONTAINING LABELS WITH VARIABLE INFORMATION PRINTED BY THERMAL TRANSFER Technopack Ind. Com. Consultoria E Representações Ltda LEGESSE, HENOK D 2853 §102 Non-Final OA 16d Pending Jun 15, 2023
18029640 COMPOSITIONS COMPRISING INACTIVATED MICROBES, AND METHODS FOR USE AND PRODUCTION THEREOF Colorado State University Research Foundation DICKENS, AMELIA NICOLE 1645 §112 Final Rejection 18d overdue Pending Mar 30, 2023
18026780 Novel Formulations of Psilocybin And Psilocin Compounds as Serotonin Agonists in Combination With 3,4 Methylenedioxymethamphetamine (MDMA) Mydecine Innovations Group Inc. SHIAO, REI TSANG 1691 §103 Non-Final OA 73d overdue Pending Mar 16, 2023
18020335 ELECTROCHEMICAL MICROFLUIDIC ASSAY DEVICES Colorado State University Research Foundation MUI, CHRISTINE T 1797 §102 Non-Final OA 70d overdue Pending Feb 08, 2023
18017074 PHOSPHOLIPID BILAYERS CATALYTICALLY PROMOTE PROTEIN REFOLDING, INHIBIT AND REVERSE PROTEIN AGGREGATE FORMATION, AND METHODS OF TREATING NEURODEGENERATIVE DISEASES USING THE SAME The Regents of the University of Colorado WEBB, WALTER E 1612 §103 Non-Final OA 38d overdue Pending Jan 19, 2023
18071815 Animal Waste Collection Assembly And Methods Of Use Thereof Ama Innovations LLC CHIN, PAUL T 3651 §103 Non-Final OA 28d overdue Pending Nov 30, 2022
17962656 Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof The Regents of the University of Colorado SEAMAN, D MARGARET M 1625 §112 Non-Final OA 60d overdue Pending Oct 10, 2022
17935688 Thiomorpholino Oligonucleotides For The Treatment of Muscular Dystrophy Murdoch University WHITEMAN, BRIAN A 1636 Other Final Rejection 16d Pending Sep 27, 2022
17913528 PHOTO REACTOR DEVICES, SYSTEMS, AND METHODS OF USE THEREOF Colorado State University Research Foundation SEGED, NEBYATE SAMUEL 1758 §103 Final Rejection 42d overdue Pending Sep 22, 2022
17913392 In Vitro Manufacturing And Purification Of Therapeutic mRNA Nature'S Toolbox, Inc. BOWERS, NATHAN ANDREW 1799 §103 Final Rejection 6d Pending Sep 21, 2022
17822992 Methods For The Identification Of UBQLN2-Mediated Amyotrophic Lateral Sclerosis (ALS) The Regents of the University of Colorado NOAKES, SUZANNE MARIE 1656 §112 Non-Final OA 28d overdue Pending Aug 29, 2022
17759402 Method for Retaining Splicing RNAs in the Nucleus Based on Chemically Modified Antisense Oligonucleotides The Regents of the University of Colorado GOLDBERG, JEANINE ANNE 1682 §103 Final Rejection 77d overdue Pending Jul 25, 2022
17744536 Identification of Host RNA Biomarkers of Infection The Regents of the University of Colorado VANNI, GEORGE STEVEN 1686 §101 Non-Final OA 89d overdue Pending May 13, 2022
17636425 Anti-C7 Antibody Or Antibody Fragment UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD TAYLOR, LIA ELAN 1641 §112 Non-Final OA 19d Pending Feb 18, 2022
17603465 DYE COMPOSITION FOR MARKING ORGANIC TISSUE WITH AN ESTHETIC AND METHOD FOR APPLYING SAME Doris Maria Hexsel WELLS, LAUREN QUINLAN 1622 §112 Non-Final OA 85d Pending Oct 13, 2021
17603276 Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins Nature'S Toolbox, Inc. SMALL, KATHERINE R 1633 §103 Final Rejection 77d overdue Pending Oct 12, 2021
17428581 Generation Of Water-Soluble Cannabinoids Utilizing Protein Cannabinoid-Carriers Trait Biosciences, Inc. TSAY, MARSHA M 1656 §103 Non-Final OA 34d Pending Aug 04, 2021
17189063 Compositions And Methods For Glycosylating Cannabinoid Compounds Trait Biosciences, Inc. KOVALENKO, MYKOLA V 1662 §112 Non-Final OA 11d overdue Pending Mar 01, 2021
17164624 Programmable Designer Therapeutic Fusogenic Secreted Gectosome Vesicles For Macromolecule Delivery And Genome Modification The Regents of the University of Colorado LEONARD, ARTHUR S 1631 §103 Final Rejection 139d overdue Pending Feb 01, 2021

Managing Berg Hill Greenleaf & Ruscitti LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month